MedPath
NMPA Approval

Levetiracetam Concentrated Solution for Injection

国药准字HJ20170341

April 20, 2022

H20170341

Drug Information

左乙拉西坦注射用浓溶液

开浦兰

注射剂

5ml:500mg

化学药品

April 20, 2022

April 19, 2027

Company Information

Applicant Company

UCB-Pharma SA

Allee de la Recherche 60, B-1070 Brussels, Belgium

Manufacturing Company

PATHEON ITALIA SPA

Monza Operations, Viale G.B. Stucchi, 110, I-20900 Monza(MB), Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

左乙拉西坦注射用浓溶液 - NMPA 批准文号 | MedPath